Skip to content

ESD Home

TechCentury

Powered by

Engineering Society of Detroit Lawrence Technological University

Tag: mRNA Vaccines

Pharmaceuticals

Esperovax, Ginkgo Bioworks partner to develop RNA-based therapeutics

PLYMOUTH—Esperovax, the Plymouth developer of oral mRNA biologics, and Boston-based Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a partnership to …

Pharmaceuticals / University Research

Esperovax signs licensing agreement with UM for new manufacturing tech for vaccines

PLYMOUTH—Esperovax, a Plymouth-based developer of oral vaccines, announced a new, exclusive licensing agreement with Innovation Partners at the University of Michigan to produce vaccines and therapeutics using a novel yeast-based …

Read the magazine:

TechCentury
Advertise or Contribute an Article

Subscribe to TechCentury.com

Top Posts

  • IEEE spring conference gets the latest on robots, EVs
  • Seven Domino's locations join Consumers Energy in EV charging for deliveries
  • $35M relief fund application goes live to help small Michigan nonprofits
  • LTU’s Blue Devil Motorsports to unveil 2023 competition vehicles April 4
  • Tim Clark named president, CEO of Hitachi Astemo Americas

Archives

Follow Us On

© The Engineering Society of Detroit   |   ABOUT